AC
AGN

Athanor Capital’s Allergan plc AGN Stock Holding History

Athanor Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-287,100
Closed -$54.9M – 422
2019
Q4 		$54.9M Buy
287,100
+47,400
+20% +$8.55M 2.5% 8
2019
Q3 		$40.3M Buy
239,700
+191,700
+399% +$31.2M 2.59% 9
2019
Q2 		$8.04M Buy
+48,000
New +$6.65M 1.03% 33

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Athanor Capital's AGN Position: Q1 2020 in Review

Athanor Capital sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 287,100 shares — an estimated $54.9M sold.

Athanor Capital first reported a position in AGN in Q2 2019 and held it in 3 quarters. The position peaked at $54.9M in Q4 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Athanor Capital reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Athanor Capital sold 287,100 Allergan plc shares in Q1 2020, an estimated $54.9M.
  • Athanor Capital first reported a position in Allergan plc in Q2 2019 and held it in 3 quarters.
  • Athanor Capital's Allergan plc position peaked at $54.9M in Q4 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Athanor Capital's 13F filing for Q1 2020, filed 14 May 2020.